Products - Psoriasis | Topic | NICE

Showing 5 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Deucravacitinib for treating active psoriatic arthritis [ID6561]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ixekizumab for treating enthesitis-related arthritis and juvenile psoriatic arthritis in people 2 to 17 years [ID6590]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tildrakizumab for treating active psoriatic arthritis [ID6724]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Zasocitinib for treating moderate to severe plaque psoriasis [ID6700]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Topical tapinarof for treating mild to severe plaque psoriasis [ID6712]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC